Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19049496 | 0.86 | GBA1 (0.30) | GBA1 | |
| SCHEMBL14338745 | 0.81 | GBA1 (0.32) | GBA1 | |
| SCHEMBL19426926 | 0.80 | CYP2C9 (0.38) | GBA1 | |
| SCHEMBL10130372 | 0.79 | — | — | |
| SCHEMBL10157050 | 0.77 | CYP1A2 (0.44) | GBA1 | |
| SCHEMBL19013077 | 0.77 | TRPA1 (0.34) | — | |
| SCHEMBL19198271 | 0.77 | TRPA1 (0.34) | — | |
| SCHEMBL17757346 | 0.75 | TRPA1 (0.50) | — | |
| SCHEMBL13963985 | 0.75 | TRPA1 (0.50) | — | |
| SCHEMBL17637121 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11834630-B2 | Solid free-flowing particulate laundry detergent composition | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-05 | — | — | US | disclosed |
| US-11192904-B2 | Silicone compounds comprising a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2021-12-07 | — | — | US | disclosed |
| US-20210130753-A1 | SOLID FREE-FLOWING PARTICULATE LAUNDRY DETERGENT COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2021-05-06 | — | — | US | disclosed |
| US-20200277546-A1 | TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2020-09-03 | — | — | US | disclosed |
| US-20200095267-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2020-03-26 | — | — | US | disclosed |
| US-10292910-B2 | Controlled release dual walled microcapsules | ENCAPSYS, LLC (US) | 2019-05-21 | — | — | US | disclosed |
| US-9902812-B2 | Consumer goods product comprising functionalised lignin oligomer | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-27 | — | — | US | disclosed |
| US-20170283735-A1 | CONTROLLED RELEASE DUAL WALLED MICROCAPSULES | ENCAPSYS, LLC (US) | 2017-10-05 | — | — | US | disclosed |
| WO-2017132100-A1 | TREATMENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-03 | — | — | WO | disclosed |
| WO-2017132101-A1 | TREATMENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-03 | — | — | WO | disclosed |
| US-20170183452-A1 | ORGANOSILICONES | PROCTER & GAMBLE (US) | 2017-06-29 | — | — | US | disclosed |
| WO-2017074997-A1 | ENCAPSULATION | ENCAPSYS, LLC (US) | 2017-05-04 | — | — | WO | disclosed |
| WO-2017048490-A1 | A PROCESS FOR MAKING A DETERGENT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2017-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200095267-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | GBA1 886/4885 |
| US-10292910-B2 | Controlled release dual walled microcapsules | MYADM, MCHR2, MCHR1 | GBA1 4248/4885 |
| US-11192904-B2 | Silicone compounds comprising a benefit agent moiety | SMCHD1, SMN1; SMN2, SGMS2 | GBA1 614/4885 |
| US-20170283735-A1 | CONTROLLED RELEASE DUAL WALLED MICROCAPSULES | MYADM, MCHR2, MCHR1 | GBA1 4248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.